Frontiers in Oncology | Thoracic Oncology

Original Research

Published on 16 Jun 2021

The Angiotensin-Converting Enzyme Inhibitory State Promotes the Transformation of Non-Small Cell Lung Cancer Blood Supply Pattern Toward Vasculogenic Mimicry Formation

in Thoracic Oncology

Kandi Xu
Huize Han
Yexin Luo
Hong Ye
Hongxia Lin
Lei Ni

Frontiers in Oncology

doi 10.3389/fonc.2021.663671

3,331 views
10 citations

Original Research

Published on 15 Jun 2021

An EBC/Plasma miRNA Signature Discriminates Lung Adenocarcinomas From Pleural Mesothelioma and Healthy Controls

in Thoracic Oncology

Alice Faversani
Chiara Favero
Laura Dioni
Angela Cecilia Pesatori
Valentina Bollati
Matteo Montoli
Valeria Musso
Andrea Terrasi
Nicola Fusco
Mario Nosotti

Frontiers in Oncology

doi 10.3389/fonc.2021.643280

4,931 views
15 citations

Original Research

Published on 14 Jun 2021

Interferon Regulatory Factor 4 Correlated With Immune Cells Infiltration Could Predict Prognosis for Patients With Lung Adenocarcinoma

in Thoracic Oncology

Xuanzong Li
Shujun Zhai
Jianbo Zhang
Dai Zhang
Shijiang Wang
Linlin Wang
Jinming Yu

Frontiers in Oncology

doi 10.3389/fonc.2021.698465

6,080 views
18 citations

Original Research

Published on 14 Jun 2021

EGFR-Mutated Squamous Cell Lung Cancer and Its Association With Outcomes

in Thoracic Oncology

Rui Jin
Ling Peng
Jiawei Shou
Jin Wang
Yin Jin
Fei Liang
Jing Zhao
Mengmeng Wu
Qin Li
Bin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.680804

18,243 views
39 citations

Mini Review

Published on 11 Jun 2021

Treatment of Advanced-Stage Large Cell Neuroendocrine Cancer (LCNEC) of the Lung: A Tale of Two Diseases

in Thoracic Oncology

Tahani Atieh
Chao H. Huang

Frontiers in Oncology

doi 10.3389/fonc.2021.667468

10,037 views
13 citations

Original Research

Published on 10 Jun 2021

Low Expression of ADCY4 Predicts Worse Survival of Lung Squamous Cell Carcinoma Based on Integrated Analysis and Immunohistochemical Verification

in Thoracic Oncology

Zhicong Liu
Lixin Ru
Zhenchao Ma

Frontiers in Oncology

doi 10.3389/fonc.2021.637733

3,755 views
4 citations

Original Research

Published on 07 Jun 2021

Identification of High-Risk of Recurrence in Clinical Stage I Non-Small Cell Lung Cancer

in Thoracic Oncology

Yasuhiro Tsutani
Yoshihisa Shimada
Hiroyuki Ito
Yoshihiro Miyata
Norihiko Ikeda
Haruhiko Nakayama
Morihito Okada

Frontiers in Oncology

doi 10.3389/fonc.2021.622742

3,104 views
5 citations

Correction

Published on 02 Jun 2021

Corrigendum: Alpha Thalassemia/Intellectual Disability X-Linked Deficiency Sensitizes Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors

in Thoracic Oncology

Tao Hou
Shun Jiang
Yapeng Wang
Yangchun Xie
Haixia Zhang
Yeqian Feng
Fang Ma
Jin’an Ma
Xianling Liu
Chunhong Hu

Frontiers in Oncology

doi 10.3389/fonc.2021.705406

1,548 views

Original Research

Published on 02 Jun 2021

Comparison of Clinical Efficacy of Alectinib Versus Crizotinib in ALK-Positive Non-Small Cell Lung Cancer: A Meta-Analysis

in Thoracic Oncology

Hao Tang
Longyu Jin
Zhang Zhang
Zhibin Jiang
Zeeshan Malik

Frontiers in Oncology

doi 10.3389/fonc.2021.646526

7,118 views
8 citations

Mini Review

Published on 01 Jun 2021

Regulatory T-Cells as an Emerging Barrier to Immune Checkpoint Inhibition in Lung Cancer

in Thoracic Oncology

Daniel R. Principe
Lauren Chiec
Nisha A. Mohindra
Hidayatullah G. Munshi

Frontiers in Oncology

doi 10.3389/fonc.2021.684098

11,690 views
70 citations

Original Research

Published on 31 May 2021

Survival Analysis and Prediction Model for Pulmonary Sarcomatoid Carcinoma Based on SEER Database

in Thoracic Oncology

Mingjing Chen
Qiao Yang
Zihan Xu
Bangyu Luo
Feng Li
Yongxin Yu
Jianguo Sun

Frontiers in Oncology

doi 10.3389/fonc.2021.630885

5,462 views
25 citations

Original Research

Published on 31 May 2021

A Retrospective Study on Using a Novel Single Needle Cone Puncture Approach for the Iodine-125 Seed Brachytherapy in Treating Patients With Thoracic Malignancy

in Thoracic Oncology

Fenge Li
Liping Wang
Yixiang Zhang
Weihong Feng
Tao Ju
Zaiping Liu
Zhenglu Wang
Xueming Du

Frontiers in Oncology

doi 10.3389/fonc.2021.640131

2,978 views
10 citations

Systematic Review

Published on 31 May 2021

Prevalence of TP-53/Rb-1 Co-Mutation in Large Cell Neuroendocrine Carcinoma

in Thoracic Oncology

Hoda Saghaeiannejad Esfahani
Cory M. Vela
Aman Chauhan

Frontiers in Oncology

doi 10.3389/fonc.2021.653153

6,395 views
15 citations

Review

Published on 28 May 2021

Angiogenesis Inhibitors in Small Cell Lung Cancer

in Thoracic Oncology

Agnese Montanino
Anna Manzo
Guido Carillio
Giuliano Palumbo
Giovanna Esposito
Vincenzo Sforza
Raffaele Costanzo
Claudia Sandomenico
Gerardo Botti
Maria C. Piccirillo

Frontiers in Oncology

doi 10.3389/fonc.2021.655316

10,441 views
53 citations

Original Research

Published on 27 May 2021

Association of PTPRD/PTPRT Mutation With Better Clinical Outcomes in NSCLC Patients Treated With Immune Checkpoint Blockades

in Thoracic Oncology

Xiaoyan Wang
Bingchen Wu
Zhengqing Yan
Guoqiang Wang
Shiqing Chen
Jian Zeng
Feng Tao
Bichun Xu
Honggang Ke
Mei Li

Frontiers in Oncology

doi 10.3389/fonc.2021.650122

5,924 views
23 citations

Original Research

Published on 27 May 2021

Absolute Lymphocyte Count Predicts Immune-Related Adverse Events in Patients With Non-Small-Cell Lung Cancer Treated With Nivolumab Monotherapy: A Multicenter Retrospective Study

in Thoracic Oncology

Saeka Egami
Hitoshi Kawazoe
Hironobu Hashimoto
Ryuji Uozumi
Toko Arami
Naomi Sakiyama
Yuichiro Ohe
Hideo Nakada
Tohru Aomori
Shinnosuke Ikemura

Frontiers in Oncology

doi 10.3389/fonc.2021.618570

6,257 views
22 citations